SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " publishing " 2,794 found 🔀 AI-powered Shuffle
If you’re at risk of Alzheimer’s, these dietary habits can help, study finds
Research suggests diet remains a relevant factor for brain health even after blood markers of dementia are present.
Universal Orlando Resort unveils Fourth of July entertainment and fireworks
Experience the Fourth of July at Universal Orlando Resort with fireworks, entertainment, activities, and dining.
Seven gastrointestinal illness cases linked to Seattle sushi restaurant, health officials say
Seven people reported getting sick after eating at the Sushi%AYCE/All You Can Eat restaurant in Seattle’s Chinatown International District.
AI Should Focus on Fixing Business Problems
Automation should not replace accountability.
5 takeaways from Supreme Court rulings on Trump, elections and LGBTQ+ rights
This term, the Supreme Court justices gave President Donald Trump more power — but not as much as he wanted.
Why the Supreme Court’s ruling could deepen Democrats’ fundraising woes
The Supreme Court’s decision on Tuesday to loosen campaign finance laws by allowing party committees to coordinate with candidates is a boon for Republicans and threatens to deepen Democratic fundraising woes.
Supreme Court sides with GOP, loosens campaign spending rules
The decision is the latest in which the Supreme Court has weighed in on campaign finance rules.
Two Dan Sullivans will be on the ballot in Alaska
The incumbent senator accuses his challenger of being a Democratic plant set up to confuse primary voters, but fellow Republican Dan J. Sullivan has said his desire to run is genuine.
Absent congressman returns to Congress after nearly four months
Rep. Tom Kean (R-New Jersey) has pledged to be “completely transparent” about what happened upon his return.
Orlando ranks No. 2 in US for freelancer business growth since 2019
Orlando ranks as the 2nd fastest-growing freelance market in the US, with significant growth in freelancer businesses since 2019.
Analysis | Democrats turn to unconventional organizing in an atypical ‘must-win’ Senate race
Alaska presents myriad challenges to political organizers.
Decrying 'egos in politics,' Wu sharpens attacks on Beacon Hill foes
Mayor Michelle Wu's deteriorating relationships in the Senate have led her to drop the veil and endorse first-time candidates running against those whom she views as thwarting her priorities.
Iran’s leverage over Strait of Hormuz snarls Trump’s push for a deal
Washington and Tehran are back at the negotiating table after a fragile ceasefire. But experts remain skeptical the two sides are close to a nuclear deal, even as calm oil markets reduce pressure to reach one.
Opinion | Protect the workers who protect our health
Massachusetts lawmakers should pass bipartisan workplace violence reforms before the legislative session ends.
Dept. of Social and Health Services announces massive data breach involving personal information
The employee may have accessed names, dates of birth and social security numbers. A total of 8,600 records were accessed.
Woman says popular oil change business left her engine in the backseat
“What they pulled out of my car looks like something from a sci-fi movie.”
Former Trump adviser Jason Miller eyed to join White House in midterms shake-up
The White House is bringing on new staff as part of a new effort to boost its messaging operation ahead of the midterm elections.
The most underrated business discipline is hospitality
How a hotel candle reminds this CEO that AI is important, but so is being human in the business environment.
Ohio Casino Control Commission seizes illegal gaming machines from Sidney business
Complaints had been filed alleging that the business was operating gaming machines in violation of state law, prompting an investigation.
Housing bill that Trump refuses to sign heads to his desk
House Speaker Mike Johnson is set to send a bipartisan housing bill to President Donald Trump’s desk Monday, but it is unclear whether he will sign it into law.
Supreme Court expands Trump’s power over the federal bureaucracy
The justices allowed the president to fire a Democratic member of the Federal Trade Commission, striking down a nearly century-old precedent intended to insulate independent agencies from political influence by the executive.
Pride, protest, and politics surround Seattle’s Egypt-Iran World Cup match
Hours before the match between Egypt and Iran kicked off in Seattle, the streets of Pioneer Square echoed with protest chants.
A Salt Lake City school’s new sports complex features a huge turf field. Neighbors say it’s a heat island
One couple said they’re no longer able to enjoy their yard because it now reeks of hot rubber.
After her insurer denied coverage of medication, she ended up in the ER
After switching Medicare Advantage plans, a woman with a weakened immune system got tangled in the preapproval process, which the insurance industry has vowed to improve.
Why resisting Trump has galvanized Black Democrats as the midterms approach
High primary turnout among Black voters in the South has given some in the party hope for upset wins in the region.
New Ballard coffee shop burglarized two months into business
Highland Espresso is recovering after thieves broke in and stole thousands of dollars worth of equipment early Thursday morning.
Cassidy, fresh off a blowup with Trump, blasts RFK Jr.’s policies
The GOP senator said a “foundation of lies” had shaped Kennedy's health stances. He also accused Trump of treating Congress as an "appendage."
Employees of downtown businesses in metro Atlanta city will get special parking
Change is coming to downtown parking in Powder Springs.
Punk rock culture meets Portland’s love of soccer and women’s sports in Cherry Bombs FC’s first season
Portland’s new pre-professional women’s soccer team plays the last home game of the short season Sunday at Lents Park.
Government overreach won’t fix youth gender medicine
The real cure for bad science is better clinical trials, not lawsuits.
Government overreach won’t fix youth gender medicine
The real cure for bad science is better clinical trials, not lawsuits.
GOP candidate with same name as senator can stay on Alaska ballot, judge rules
Supporters of incumbent Republican Sen. Dan Sullivan say a challenger with the same name is not running in “good faith,” but a judge says that is not an issue.
Vancouver turns its Science World museum into a giant 17-story soccer ball for the World Cup
It started with a whimsical idea
Scratching a bug bite feels good but science says it’s a bad idea
Researchers have gained a better understanding of why we have an itch to scratch.
Alito and Kagan’s telling exchange about race and politics
Both sides of the debate in the court’s case on temporary protected status could have used a little more realism.
How the dairy industry pushed Trump for migrant labor, and won
President Donald Trump was expected to announce the expansion of a guest-worker program to the dairy industry at a Wisconsin event. Instead, the news came out in a press release, angering immigration hard-liners.
Pete Buttigieg says he was the victim of bogus report to child protective services
The high-profile Democrat and potential 2028 presidential contender said he couldn’t see his twins for 24 hours as report was investigated.
Health Brief: Inside the CDC nominee’s finances
Plus: Supreme Court ruling sparks health worker deportation fears
Healey’s $305M economic development bill boosts defense, startups
This week, the Legislature's economic development committee released its own version of the bill, which includes money for defense and AI industries.
Sugar is not uniquely bad for you. But it’s undermining good habits.
Is sugar more harmful than other carbohydrates? The evidence is far from compelling.
Massachusetts marijuana legalization repeal question battle heats up
Cannabis industry leaders are urging businesses to take the initiative seriously after many previously dismissed its chances.
Opinion | Don't apply politics to scientific research
Under recently proposed rules, federal grants could be terminated midstream for reasons having little to do with science or merit.
Inside Trump’s plans for retribution and other lesser-known allegations in ‘Regime Change’
A new book from two Washington reporters reveals what took place inside the White House after President Donald Trump’s return to power.
Supreme Court hands Trump major victories on his immigration agenda
In two ideologically spit rulings that could affect millions, justices say the administration can deport some migrants and turn others away at the border.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Trump’s politics of emergencies leaves GOP allies scrambling again
In upending plans to sign a bipartisan housing bill, the president illustrated one of his favored tactics: declaring a policy preference to be an emergency.
In second term, is Wu warming to business leaders?
In her second term, Boston Mayor Michelle Wu is developing closer ties with business leaders.
Democratic socialists cemented power in New York. Next, the rest of the country?
The Democratic Socialists of America won with support outside their usual base. Winning outside New York may be a different challenge.
We’re dermatologists. Sunscreen isn’t the problem.
Every year, a safe-sunscreen guide sparks needless concern.
Susan Collins is testing whether old school politics still work
In the modern era, political activists want their representatives to fall strictly in line. To the base, the independent centrist is no longer a hero; they are a villain to be purged. But Susan Collins has a pitch that she is an independent voice.
How a New York race became the first front in the AI industry’s midterm war
Competing AI interests poured millions into the Democratic primary, a taste of more spending to come this fall and elections beyond.
Scientists have just unlocked the secrets of an ancient scroll torched by Mount Vesuvius
After a centuries-long struggle, scholars managed to read five feet of text, using machine-learning methods they hope can unlock further discoveries.
World Cup crowds give downtown businesses a boost
A doughnut for breakfast? Not everyone knew! One Atlanta shop is introducing World Cup visitors to a sweet American tradition while building a future beyond the tournament. 🍩⚽
White House asks Congress for $88 billion for Iran war
The request mostly includes money for the Pentagon, with $67 billion going toward replenishing the military’s stocks of munitions and the cost of sending so many forces to the Middle East.
Trio behind string of business burglaries caught after chase through Tucker
Police said the suspects threw cash register tills and other stolen items from the vehicle.
Trump abruptly cancels signing of bipartisan bill on affordable housing
The president posted on social media that the signing was off until the Senate passes his election integrity bill. It is unclear whether he intends to kill the housing bill.
Shuttered Public Market bar misses World Cup business
An eviction dispute has shuttered The Pine Bar at Boston Public Market, just as downtown perks up around the World Cup.
The 4 GOP senators who broke ranks and voted to block Trump from resuming Iran war
The president seethed at Susan Collins, Bill Cassidy, Lisa Murkowski and Rand Paul after the war powers resolution passed, saying: "I will get it done, one way or the other."
How a $0 co-pay saves billions
Bringing down drug costs is the first step to improve health care affordability.
Rockstar Games Announces Pre-Orders for Grand Theft Auto VI
Rockstar Games®, a publishing label of Take-Two Interactive Software, Inc. (NASDAQ: TTWO), is excited to announce that pre-orders for Grand Theft Auto VI wil...
Inside the “simple job” in government Platner held before Senate run
Platner once said the office of harbormaster of Sullivan, Maine, might've been his ceiling in politics.
After clashes, Senate Republicans prepare to talk it out with Trump
Trump’s relationship with some members has deteriorated — not least because he helped to defeat two of them in GOP primaries.
Are AI chatbots like ChatGPT politically biased? We tested them.
The Post tested ChatGPT, Gemini and other chatbots with political questions, and the results show that the AI tools have different political leanings.
Senate President J. Stuart Adams — burdened by data center fallout
After more than 20 years in the Legislature, Senate President J. Stuart Adams lost his bid for reelection Tuesday, conceding defeat to Stephanie Hollist.
Utah GOP Rep. Trevor Lee, known for inflammatory posts, ousted in GOP primary
Bob Stevenson beats incumbent state Rep. Trevor Lee in the Republican primary for Utah's House District 16 race.
Friday’s World Cup match in Seattle draws conversations about politics and Pride
For the first time in World Cup history, Friday’s Game has been designated “Welcome to Seattle: This is How we Pride,” a kickoff to Pride weekend in Seattle.
Do the Utah Jazz have concerns about Darryn Peterson’s health? Here’s what Austin Ainge said.
Darryn Peterson faced a lot of questions this year. The Utah Jazz are satisfied with his answers. Here's why.
What the Reflecting Pool debacle says about Trump and his presidency
The contrast from what Trump promised in April, when he announced his plan to repair and refurbish the pool, has been nightmarish.
Senate votes to block Trump from resuming Iran war
The Senate passed the first war powers resolution since the start of the Iran conflict, but Republicans argue it does not have the force of law.
FIFA called Haitian jerseys ‘too political.’ Haitian fans showed up anyway.
Haitian fans all over Boston use their fashion to show up.
1 hurt after vehicle hits Dayton business
The crash was reported shortly after 10:30 a.m. on W. Third Street.
CDC’s chief blocked a covid vaccine study. Now it’s in a top medical journal.
The study found that the vaccine reduced the risk of emergency department visits and hospitalizations among healthy adults by about half last winter.
For democracy to survive, we must embrace our interdependence
Our mandate then was to gain independence. But in today’s hyperconnected world, it’s all about standing together.
Analysis | Mamdani views 2026 House endorsements as a 2028 test
The New York mayor wants to remake the Democratic Party.
Want a younger brain? Exercise in your 40s may help.
Even if you’ve never worked out, starting in middle age — even with brisk walks — can have a bigger impact on your brain than you think.
Why prediction markets’ election picks are useful, even when they seem wrong
A Post analysis found that primary candidates ended up winning about as often as bettors thought they would.
Mamdani and AI industry flex political power in New York, plus more to watch in Tuesday's primaries
Two factions in the AI industry are clashing in a Democratic primary for a U.S. House seat
Entertainment Tuesday Trivia: Test your movie history knowlege
Let us know what you think!
Cambridge city manager says Wu’s business summits are a ‘wakeup call’
Boston Mayor Michelle Wu has held three economic summits to address issues facing the region. Yi-An Huang has attended all three.
Vance says Iran agrees to nuclear inspections, as under Obama deal
Conversations with inspectors from the International Atomic Energy Agency could occur as soon as Monday, the vice president said, as negotiations continue in Switzerland.
Blazers owner Tom Dundon will address business group this week
The appearance comes as Portland’s NBA team faces big questions about its future.
In Utah, here’s why some measles exposure sites never appear in public alerts
A person who doesn’t know they are infected with measles may enter a business in Utah and unknowingly expose people they pass by or sit near — yet that business may never appear in public health alerts.
In Utah, here’s why some measles exposure sites never appear in public alerts
A person who doesn’t know they are infected with measles may enter a business in Utah and unknowingly expose people they pass by or sit near — yet that business may never appear in public health alerts.
AP Decision Notes: What to expect in South Carolina’s state primary runoff
Two of South Carolina’s top officeholders will compete one-on-one for the Republican nomination for governor in a primary runoff election on Tuesday
AP Decision Notes: What to expect in New York’s state primary
Democratic nomination contests for New York’s seats in the closely divided U.S. House take center stage Tuesday in a state primary
Hot weather can make these 9 health conditions worse
Sweltering days can trigger flare-ups or, in some cases, even more severe complications.
1 in 3 Americans use chatbots for health advice. These 6 patients explain why.
They say cost, speed and other considerations drove them to AI. They are also learning what to believe and what to take with caution.
Why luxury steakhouses are such big business in Boston
New, ever-pricier steakhouses keep opening in Boston. Can they all survive in this city?
Road to cannabis cafes is long and painful for weed businesses
Cannabis entrepreneurs have sunk lots of dollars into weed cafes, but now they're waiting for towns and state officials to let them move forward.
Opinion | Are Boomers to blame for everything?
Three writers debate whether older Americans are holding on too long — or whether younger generations need to do more to claim their place.
Vermont’s Governor Scott vetoes Legislature’s attempt at healthcare reform
The bill was designed to fast-track premium savings for public school employees and people buying plans on Vermont’s Affordable Care Act marketplace.
Gordon Monson: To my father, and all the fathers out there
Tribune columnist Gordon Monson reflects on his father’s impact 25 years after his death.
The new kings of media are in your inbox
A new class of independent creators is building sustainable media businesses — one newsletter at a time.
Trump wanted out of the Iran war. The aftermath is pulling him back in.
The ceasefire reopened diplomacy, but it also left Washington to manage Iran’s leverage, Israel’s attacks and a MAGA backlash.
Opinion
Politicians now think it is fine not to release their tax returns. But that only feeds distrust.
Suspect fleeing officers crashes into Pittsburgh business & gets away on foot, police say
The man was wanted on felony charges of robbery and domestic violence.
Joe Tirio: The most dishonest thing in American politics isn’t a candidate. It’s a map.
"The argument that 'the other side does it too' is the weakest possible defense of a bad practice," McHenry County Clerk Joe Tirio writes of gerrymandering in a guest opinion.
Oregon’s ancient landslides store lots of carbon, UO study shows
When it comes to carbon storage, trees get a lot of attention. But researchers are now finding carbon trapped in unusual places, including ancient landslides.
Health officials warn visitors that cannabis in Washington can be stronger than in other parts of US
The Washington Department of Health is warning FIFA visitors about the strength of cannabis in Washington.